Application 021035

Type
NDA
Sponsor
UCB INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001KEPPRALEVETIRACETAMTABLET;ORAL250MGYesNo
002KEPPRALEVETIRACETAMTABLET;ORAL500MGYesNo
003KEPPRALEVETIRACETAMTABLET;ORAL750MGYesNo
004KEPPRALEVETIRACETAMTABLET;ORAL1GMYesYes

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
21695-070KeppralevetiracetamRebel Distributors CorpNDACurrent
50474-594KeppralevetiracetamUCB, Inc.NDACurrent
50474-594KeppralevetiracetamUCB, Inc.NDACurrent
50474-594KeppralevetiracetamUCB, Inc.NDACurrent
50474-594KeppralevetiracetamUCB, Inc.NDACurrent
50474-595KeppralevetiracetamUCB, Inc.NDACurrent
50474-595KeppralevetiracetamUCB, Inc.NDACurrent
50474-595KeppralevetiracetamUCB, Inc.NDACurrent
50474-595KeppralevetiracetamUCB, Inc.NDACurrent
50474-596KeppralevetiracetamUCB, Inc.NDACurrent
50474-596KeppralevetiracetamUCB, Inc.NDACurrent
50474-596KeppralevetiracetamUCB, Inc.NDACurrent
50474-596KeppralevetiracetamUCB, Inc.NDACurrent
50474-597KeppralevetiracetamUCB, Inc.NDACurrent
50474-597KeppralevetiracetamUCB, Inc.NDACurrent
50474-597KeppralevetiracetamUCB, Inc.NDACurrent
50474-597KeppralevetiracetamUCB, Inc.NDACurrent
55289-097KeppralevetiracetamPD-Rx Pharmaceuticals, Inc.NDACurrent
55289-097KeppralevetiracetamPD-Rx Pharmaceuticals, Inc.NDACurrent
55289-097KeppralevetiracetamPD-Rx Pharmaceuticals, Inc.NDACurrent
55289-097KeppralevetiracetamPD-Rx Pharmaceuticals, Inc.NDACurrent
55289-097KeppralevetiracetamPD-Rx Pharmaceuticals, Inc.NDACurrent
55289-097KeppralevetiracetamPD-Rx Pharmaceuticals, Inc.NDACurrent
65084-457KeppralevetiracetamMckesson Rxpak IncNDACurrent
65084-458KeppralevetiracetamMckesson Rxpak IncNDACurrent
65084-459KeppralevetiracetamMckesson Rxpak IncNDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
77817SUPPL 2024-03-13
77796SUPPL 2024-03-13
77795SUPPL 2024-03-13
75350SUPPL 2023-09-05
75341SUPPL 2023-09-01
75136SUPPL 2023-08-18
75118SUPPL 2023-08-18
72411SUPPL2022-10-19
64806SUPPL2020-10-02
64805SUPPL2020-10-02
64778SUPPL2020-10-01
60652SUPPL2019-10-24
60644SUPPL2019-10-24
60643SUPPL2019-10-24
50216SUPPL2017-10-30
50210SUPPL2017-10-27
48146SUPPL2017-04-27
48108SUPPL2017-04-25
45766SUPPL2016-11-01
45706SUPPL2016-10-28
26543SUPPL2015-03-12
14213SUPPL2015-03-12
26544SUPPL2014-08-11
35942SUPPL2014-08-08
4114SUPPL2014-03-11
14212SUPPL2014-03-10
14211SUPPL2013-07-30
4113SUPPL2013-07-26
26541SUPPL2011-12-21
26540SUPPL2011-12-21
26537SUPPL2011-12-21
4112SUPPL2011-12-21
4109SUPPL2011-12-21
35941SUPPL2011-12-20
35940SUPPL2011-12-20
35938SUPPL2011-12-20
14210SUPPL2011-12-20
14207SUPPL2011-12-20
26542SUPPL2011-08-12
14209SUPPL2009-05-13
14208SUPPL2009-05-13
4111SUPPL2009-05-04
4110SUPPL2009-05-04
52946SUPPL2008-06-03
52944SUPPL2008-06-03
52943SUPPL2008-06-03
52311SUPPL2008-06-03
52310SUPPL2008-06-03
52309SUPPL2008-06-03
52308SUPPL2008-06-03
52307SUPPL2008-06-03
52306SUPPL2008-06-03
4108SUPPL2007-09-25
23618ORIG2007-03-28
26539SUPPL2007-03-23
14206SUPPL2007-03-23
35939SUPPL2006-08-18
26538SUPPL2006-08-18
14205SUPPL2006-08-18
4107SUPPL2006-08-18
4105SUPPL2006-01-30
26536SUPPL2006-01-20
35937SUPPL2005-06-23
4106SUPPL2005-06-23
4104SUPPL2004-10-29
4103SUPPL2004-10-29
4102SUPPL2003-09-09
4101SUPPL2002-05-22
4100SUPPL2002-05-22
41891ORIG1999-11-30
14204ORIG1999-11-30
4099ORIG1999-11-30
63936ORIG1900-01-01
63935ORIG1900-01-01
63934ORIG1900-01-01
63933ORIG1900-01-01
63932ORIG1900-01-01
63931ORIG1900-01-01
52000SUPPL1900-01-01
51999SUPPL1900-01-01
51998SUPPL1900-01-01
51997SUPPL1900-01-01
51996SUPPL1900-01-01